Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

U.S. President Donald Trump on Friday signed an executive order directing the heads of government agencies to grant federal ...

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

The state's insurance regulator has been seeking such information as patient names, dates of birth and prescription details.

UnitedHealth Group's pharmacy business, Optum Rx, said it is eliminating up to 25% of reauthorizations for prescription drugs to simplify access for consumers.

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...

What is it that the PBM industry doesn’t want you to know?” asked the CEO of the Florida Pharmacy Association.

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.